12:00 AM
 | 
Mar 19, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Truvada emtricitabine/tenofovir regulatory update

FDA's Antiviral Drugs Advisory Committee will meet on May 10 to discuss an sNDA from Gilead for Truvada emtricitabine/tenofovir for...

Read the full 77 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >